1,034
Views
14
CrossRef citations to date
0
Altmetric
Brief Report

Brucella CβG induces a dual pro- and anti-inflammatory response leading to a transient neutrophil recruitment

, , , &
Pages 19-28 | Received 22 Aug 2014, Accepted 17 Oct 2014, Published online: 16 Mar 2015

References

  • Ian Maudlin SW-M. The Control of Neglected Zoonotic Diseases – A Route to Poverty Alleviation. Geneva: WHO, 2006.
  • de Jong MF, Tsolis RM. Brucellosis and type IV secretion. Future Microbiol 2012; 7:47-58; PMID:22191446; http://dx.doi.org/10.2217/fmb.11.136
  • Lacerda TL, Salcedo SP, Gorvel JP. Brucella T4SS: the VIP pass inside host cells. Curr Opin Microbiol 2013; 16:45-51; PMID:23318140; http://dx.doi.org/10.1016/j.mib.2012.11.005
  • Salcedo SP, Marchesini MI, Lelouard H, Fugier E, Jolly G, Balor S, Muller A, Lapaque N, Demaria O, Alexopoulou L, et al. Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1. PLoS Pathogens 2008; 4:e21; PMID:18266466; http://dx.doi.org/10.1371/journal.ppat.0040021
  • Salcedo SP, Marchesini MI, Degos C, Terwagne M, Von Bargen K, Lepidi H, Herrmann CK, Santos Lacerda TL, Imbert PR, Pierre P, et al. BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions. Front Cell Infect Microbiol 2013; 3:28; PMID:23847770; http://dx.doi.org/10.3389/fcimb.2013.00028
  • Conde-Alvarez R, Arce-Gorvel V, Iriarte M, Mancek-Keber M, Barquero-Calvo E, Palacios-Chaves L, Chacon-Diaz C, Chaves-Olarte E, Martirosyan A, von Bargen K, et al. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. PLoS Pathog 2012; 8:e1002675; PMID:22589715; http://dx.doi.org/10.1371/journal.ppat.1002675
  • Arellano-Reynoso B, Lapaque N, Salcedo S, Briones G, Ciocchini AE, Ugalde R, Moreno E, Moriyon I, Gorvel JP. Cyclic beta-1,2-glucan is a Brucella virulence factor required for intracellular survival. Nat Immunol 2005; 6:618-25; PMID:15880113; http://dx.doi.org/10.1038/ni1202
  • Martirosyan A, Perez-Gutierrez C, Banchereau R, Dutartre H, Lecine P, Dullaers M, Mello M, Salcedo SP, Muller A, Leserman L, et al. Brucella beta 1,2 cyclic glucan is an activator of human and mouse dendritic cells. PLoS Pathog 2012; 8:e1002983; PMID:23166489; http://dx.doi.org/10.1371/journal.ppat.1002983
  • Posselt G, Schwarz H, Duschl A, Horejs-Hoeck J. Suppressor of cytokine signaling 2 is a feedback inhibitor of TLR-induced activation in human monocyte-derived dendritic cells. J Immunol 2011; 187:2875-84; PMID:21844389; http://dx.doi.org/10.4049/jimmunol.1003348
  • McColl SR, Clark-Lewis I. Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists. J Immunol 1999; 163:2829-35; PMID:10453028
  • Krebs DL, Hilton DJ. SOCS: physiological suppressors of cytokine signaling. J Cell Sci 2000; 113(Pt 16):2813-9; PMID:10910765
  • Carow B, Rottenberg ME. SOCS3, a major regulator of infection and inflammation. Front Immunol 2014; 5:58; PMID:24600449; http://dx.doi.org/10.3389/fimmu.2014.00058
  • Babon JJ, Nicola NA. The biology and mechanism of action of suppressor of cytokine signaling 3. Growth Factors 2012; 30:207-19; PMID:22574771; http://dx.doi.org/10.3109/08977194.2012.687375
  • Danchuk S, Ylostalo JH, Hossain F, Sorge R, Ramsey A, Bonvillain RW, Lasky JA, Bunnell BA, Welsh DA, Prockop DJ, et al. Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-alpha-induced protein 6. Stem Cell Res Ther 2011; 2:27; PMID:21569482; http://dx.doi.org/10.1186/scrt68
  • Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood 2011; 118:330-8; PMID:21551236; http://dx.doi.org/10.1182/blood-2010-12-327353
  • Anderson KJ, Allen RL. Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells. Immunology 2009; 127:8-17; PMID:19368561; http://dx.doi.org/10.1111/j.1365-2567.2009.03097.x
  • Katz HR. Inhibition of inflammatory responses by leukocyte Ig-like receptors. Adv Immunol 2006; 91:251-72; PMID:16938543; http://dx.doi.org/10.1016/S0065-2776(06)91007-4
  • Trabanelli S, Ocadlikova D, Ciciarello M, Salvestrini V, Lecciso M, Jandus C, Metz R, Evangelisti C, Laury-Kleintop L, Romero P, et al. The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. J Immunol 2014; 192:1231-40; PMID:24391212; http://dx.doi.org/10.4049/jimmunol.1300720
  • Spera JM, Herrmann CK, Roset MS, Comerci DJ, Ugalde JE. A Brucella virulence factor targets macrophages to trigger B-cell proliferation. J Biol Chem 2013; 288:20208-16; PMID:23720774; http://dx.doi.org/10.1074/jbc.M113.453282
  • Spera JM, Ugalde JE, Mucci J, Comerci DJ, Ugalde RA. A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection. Proc Nat Acad Sci U S A 2006; 103:16514-9; PMID:17053080; http://dx.doi.org/10.1073/pnas.0603362103
  • Barquero-Calvo E, Martirosyan A, Ordonez-Rueda D, Arce-Gorvel V, Alfaro-Alarcon A, Lepidi H, Malissen B, Malissen M, Gorvel JP, Moreno E. Neutrophils exert a suppressive effect on Th1 responses to intracellular pathogen Brucella abortus. PLoS Pathog 2013; 9:e1003167; PMID:23458832; http://dx.doi.org/10.1371/journal.ppat.1003167
  • Copin R, Vitry MA, Hanot Mambres D, Machelart A, De Trez C, Vanderwinden JM, Magez S, Akira S, Ryffel B, Carlier Y, et al. In situ microscopy analysis reveals local innate immune response developed around Brucella infected cells in resistant and susceptible mice. PLoS Pathog 2012; 8:e1002575; PMID:22479178; http://dx.doi.org/10.1371/journal.ppat.1002575
  • Tabynov K, Kydyrbayev Z, Ryskeldinova S, Yespembetov B, Zinina N, Assanzhanova N, Kozhamkulov Y, Inkarbekov D, Gotskina T, Sansyzbay A. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection. Vaccine 2014; 32:2034-41; PMID:24598723; http://dx.doi.org/10.1016/j.vaccine.2014.02.058

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.